Clinical Trial Update: The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma [NA]

View source ↗

Summary

A clinical trial (NCT04742920) evaluating embolization of the middle meningeal artery for chronic subdural hematoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• Onyx (ethylene-vinyl alcohol copolymer (EVOH) embolic agent)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Hematoma, Subdural, Chronic, Brain Diseases | NA | Status: TERMINATED